Kiora Pharmaceuticals (KPRX) Other Accumulated Expenses (2020 - 2022)

Kiora Pharmaceuticals (KPRX) has 3 years of Other Accumulated Expenses data on file, last reported at $15630.0 in Q3 2022.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $15630.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $15630.0 (changed N/A YoY) and the FY2021 annual result came in at $28961.0, down 77.33% from the prior year.
• Other Accumulated Expenses fell to $15630.0 in Q3 2022, from $28961.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $127730.0 in Q4 2020 to a low of $15630.0 in Q3 2022.
• A 3-year average of $57440.3 and a median of $28961.0 in 2021 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 77.33% in 2021, down 77.33% in 2021.
• Tracing KPRX's Other Accumulated Expenses over 3 years: stood at $127730.0 in 2020, then tumbled by 77.33% to $28961.0 in 2021, then plunged by 46.03% to $15630.0 in 2022.
• The last three Other Accumulated Expenses figures came in at $15630.0 (Q3 2022), $28961.0 (Q4 2021), and $127730.0 (Q4 2020), per Business Quant data.